LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Suono Bio

Suono Bio is developing platform technology designed to enable ultra-rapid delivery of therapeutics, including proteins and nucleic acids, to the gastrointestinal (GI) tract. This technology has the potential to eliminate the need for formulation or encapsulation of the therapeutic and is amenable to use in multiple settings, including at home as well as in the clinic. The ability to deliver a broad range of therapies shows great promise in enhancing outcomes in a variety of diseases

  • Robert Langer, ScD Co-Founder
  • Amy Schulman Co-Founder
  • Giovanni Traverso, MD, PhD Co-Founder
  • Carl Schoellhammer, PhD Co-Founder